
Investors have piled into Hims & Hers Health (HIMS) shares in recent sessions on the back of a key regulatory update and a bullish research report from JPMorgan.
The recent momentum has helped HIMS rip through its major moving averages (MAs), signaling that the bulls are now taking back control across multiple timeframes.